NDAQ vs VNDA · P/E 41, rev $2.53B vs rev $102.2M
Nasdaq Inc (NDAQ) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
NDAQ currently screens at market cap $51.71B and trailing P/E 40.8. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the NDAQ and VNDA stock pages for the full models.
Not investment advice.